GENE
En esta anunciaron offering hace poco, la semana pasada pegó subidón.
AmericanDepositary Shares(“ADSs”), each representing six hundred (600) of the Company’s ordinary shares, at a purchase price of$2.00per ADS -or in Australian dollars $0.0053per GTG Share. The closing of the offering is expectedto occur in the United States on or about 22April 2020, subject to the satisfaction of customary closingconditions.The gross proceeds to the Company from this offering are expected to be approximately USD 1.44million,before deducting the placement agent’s fees and other offering expenses payable by the Company. TheCompany intends to use the net proceeds to fund capacity for COVID-19 testing anddevelopment of polygenic risk score testing and general working capital.